Home › Funds › Aisling Capital Management LP › SRRK
Aisling Capital Management LP position in SRRK
SCHOLAR ROCK HLDG CORP · Health Care
Aisling Capital Management LP reported holding 42,031 shares of SRRK (SCHOLAR ROCK HLDG CORP) in its Q3 2026 13F filing — a position valued at US$2.0M, representing 0.68% of its reported portfolio and ranking #11 among its reported holdings. Aisling Capital Management LP has disclosed SRRK holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Aisling Capital Management LP's SRRK position evolved
Aisling Capital Management LP first disclosed a stake in SRRK in Q3 2025 at 77,031 shares (US$2.9M). The position peaked in Q2 2026 at 77,031 shares, worth US$4.2M. Across 5 filings, Aisling Capital Management LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 42,031 shares valued at US$2.0M — a reduction of -35,000 shares quarter over quarter.. Notable position changes include a 45% trim in Q3 2026 (shares fell 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 77.03K | $2.87M | New |
| Q4 2025 | 77.03K | $3.39M | Hold |
| Q1 2026 | 77.03K | $3.79M | Hold |
| Q2 2026 | 77.03K | $4.24M | Hold |
| Q3 2026 | 42.03K | $2.03M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SRRK and 13F data
SRRK (SCHOLAR ROCK HLDG CORP) is a Health Care company. 49 other funds we track also report a position in SRRK — the largest reported positions include Siren, L.L.C. (US$453.0M), Samsara BioCapital, LLC (US$379.4M), Orbis Allan Gray Ltd (US$326.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SRRK
- Siren, L.L.C. 9.38M sh · $453.00M · Q3 2026
- Samsara BioCapital, LLC 6.90M sh · $379.37M · Q2 2026
- Orbis Allan Gray Ltd 5.93M sh · $326.34M · Q2 2026
- Redmile Group, LLC 4.31M sh · $237.11M · Q2 2026
- Bellevue Group AG 2.45M sh · $134.73M · Q2 2026
- Hood River Capital Management LLC 2.22M sh · $122.36M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 2.21M sh · $121.31M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 2.11M sh · $116.13M · Q2 2026
- Integral Health Asset Management, LLC 750.00K sh · $41.25M · Q2 2026
- Rock Springs Capital Management LP 715.45K sh · $39.35M · Q2 2026
- Casdin Capital 665.00K sh · $36.58M · Q2 2026
- Eagle Health Investments LP 555.27K sh · $30.54M · Q2 2026
More on Aisling Capital Management LP
FAQ
How long has Aisling Capital Management LP held SRRK?
Aisling Capital Management LP has disclosed SRRK holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is Aisling Capital Management LP's current position in SRRK?
As of Q3 2026, Aisling Capital Management LP holds 42.03K shares of SRRK (SCHOLAR ROCK HLDG CORP), valued at $2.03M, representing 0.68% of its reported portfolio and ranking #11.
Has Aisling Capital Management LP been buying or selling SRRK?
In the latest 13F filing (Q3 2026), Aisling Capital Management LP reduced its position in SRRK. The position peaked in Q2 2026 at 77.03K shares.
Which other funds hold SRRK?
Other major institutional holders of SRRK include Siren, L.L.C., Samsara BioCapital, LLC, Orbis Allan Gray Ltd, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.